| Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable … K Dheda, JD Limberis, E Pietersen, J Phelan, A Esmail, M Lesosky, ... The lancet Respiratory medicine 5 (4), 269-281, 2017 | 124 | 2017 |
| Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results? G Theron, R Venter, G Calligaro, L Smith, J Limberis, R Meldau, ... Clinical Infectious Diseases 62 (8), 995-1001, 2016 | 121 | 2016 |
| Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments G Theron, J Peter, G Calligaro, R Meldau, C Hanrahan, H Khalfey, ... Scientific reports 4 (1), 1-10, 2014 | 116 | 2014 |
| Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial GL Calligaro, LS Zijenah, JG Peter, G Theron, V Buser, R McNerney, ... The Lancet Infectious Diseases 17 (4), 441-450, 2017 | 76 | 2017 |
| False-positive Xpert MTB/RIF results in retested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes G Theron, R Venter, L Smith, A Esmail, P Randall, V Sood, S Oelfese, ... Journal of clinical microbiology 56 (3), e01696-17, 2018 | 75 | 2018 |
| Deletion of IL-4 Receptor Alpha on Dendritic Cells Renders BALB/c Mice Hypersusceptible to Leishmania major Infection R Hurdayal, NE Nieuwenhuizen, M Revaz-Breton, L Smith, JC Hoving, ... PLoS pathogens 9 (10), e1003699, 2013 | 54 | 2013 |
| Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action R McNerney, TG Clark, S Campino, C Rodrigues, D Dolinger, L Smith, ... International Journal of Infectious Diseases 56, 130-135, 2017 | 50 | 2017 |
| Osteoarticular tuberculosis. MA Kosinski, LC Smith Clinics in podiatric medicine and surgery 13 (4), 725-739, 1996 | 22 | 1996 |
| Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments. Sci Rep. 2014; 4: 5658 G Theron, J Peter, G Calligaro, R Meldau, C Hanrahan, H Khalfey, ... | 18 | |
| Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis G Theron, J Limberis, R Venter, L Smith, E Pietersen, A Esmail, ... Nature medicine 26 (9), 1435-1443, 2020 | 13 | 2020 |
| The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis–Specific Host Immunity Through the Glucocorticoid Receptor M Tomasicchio, M Davids, A Pooran, G Theron, L Smith, L Semple, ... The Journal of infectious diseases 219 (8), 1329-1337, 2019 | 4 | 2019 |
| The frequency and effect of granulocytic myeloid-derived suppressor cells on mycobacterial survival in patients with tuberculosis: a preliminary report M Davids, A Pooran, L Smith, M Tomasicchio, K Dheda Frontiers in immunology 12, 676679, 2021 | 3 | 2021 |
| Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia GD Bailey, L Doolan, A Baskar, LC Smith, CH Seedhouse Scientific reports 10 (1), 1-7, 2020 | 3 | 2020 |
| Host defences of invertebrates to pathogens and parasites CJR Coates, AF Rowley, LC Smith, MMA Whitten Invertebrate Pathology, 1, 2022 | 2 | 2022 |
| NUCLEAR CROSS SECTIONS OF NEGATIVE AND POSITIVE PIONS MW Aarons, J Ashkin, F Feiner, JG Gorman, L Smith PHYSICAL REVIEW 90 (2), 342-342, 1953 | 2 | 1953 |
| Frequency and clinical profile of false positive Xpert MTB/RIF results in patients previously treated for tuberculosis G Theron, R Venter, L Smith, GL Calligaro, A Esmail, RM Warren, ... A26. DIAGNOSIS AND TREATMENT OF TUBERCULOSIS, A1171-A1171, 2017 | 1 | 2017 |
| PS1022 PREFERENTIAL TRANSCRIPTION OF THE MUTATED ALLELE IN NPM1 MUTATED ACUTE MYELOID LEUKAEMIA G Bailey, A Baskar, L Smith, N Russell, C Seedhouse HemaSphere 3 (S1), 460, 2019 | | 2019 |
| Bacterial And Host Determinants Of Infectiousness In Patients With Drug-Susceptible Or Drug-Resistant Tuberculosis G Theron, L Smith, JD Limberis, R Venter, A Esmail, R McNerney, ... D96. INFECTIOUSNESS AND TRANSMISSION OF TUBERCULOSIS, A7319-A7319, 2017 | | 2017 |
| The Injectable Contraceptive Medroxyprogesterone Acetate Decreases Peripheral Effector Cell-Mediated Mycobacterium Tuberculosis Containment Through Immunosuppression Involving … M Tomasicchio, G Theron, M Davids, AS Pooran, L Smith, L Semple, ... B17. MYCOBACTERIAL HOST DEFENSES, A2905-A2905, 2017 | | 2017 |
| A26 DIAGNOSIS AND TREATMENT OF TUBERCULOSIS: Frequency And Clinical Profile Of False Positive Xpert Mtb/rif Results In Patients Previously Treated For Tuberculosis G Theron, R Venter, L Smith, GL Calligaro, A Esmail, RM Warren, ... American Journal of Respiratory and Critical Care Medicine 195, 2017 | | 2017 |
